Takashi Niizeki
Kurume, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Real-World Evidence from a Nationwide Prospective Study of the Efficacy/Safety of Systemic Therapy for Unresectable Hepatocellular Carcinoma: First 1,000 Patients of the PRISM Study.
Journal: Liver cancer
Published: December 03, 2025
Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: November 03, 2025
The Impact of Rifaximin on Hepatic Encephalopathy during Lenvatinib Therapy in Patients with Hepatocellular Carcinoma and Splenorenal Shunt.
Journal: Internal medicine (Tokyo, Japan)
Published: October 15, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: August 13, 2025
Fatal portal vein thrombosis following combination therapy with atezolizumab plus bevacizumab for hepatocellular carcinoma: an autopsy case report.
Journal: Clinical journal of gastroenterology
Published: April 22, 2025
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria.
Journal: Journal of gastroenterology and hepatology
Published: March 11, 2025
Efficacy and safety of lenvatinib-transcatheter arterial chemoembolization sequential therapy for hepatocellular carcinoma within the up-to-seven criteria.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 30, 2025
Surgical and Oncological Outcomes of Conversion Surgery After Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Locally Advanced Hepatocellular Carcinoma.
Journal: Annals of gastroenterological surgery
Published: January 14, 2025
Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan.
Journal: Journal of cancer research and clinical oncology
Published: November 25, 2024
A Rare Case of Primary Hepatic Undifferentiated Pleomorphic Sarcoma: Exploring Cancer-related Gene Mutations.
Journal: Internal medicine (Tokyo, Japan)
Published: November 10, 2024
Efficacy of Atezolizumab Plus Bevacizumab-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: September 03, 2024
A Rare Case of Undifferentiated Carcinoma of the Liver Arising in the Context of Primary Biliary Cholangitis.
Journal: Internal medicine (Tokyo, Japan)
Published: August 13, 2024
Last Updated: 09/26/2026